HPRT1: Key Enzyme in DNA Replication and Neurodegenerative Diseases

Target Name: HPRT1

NCBI ID: G3251

HPRT1

HPRT1: Key Enzyme in DNA Replication and Neurodegenerative Diseases

HPRT1, also known as hypoxanthine-guanine phosphoribosyltransferase 1, is a gene that encodes a protein located in the nucleoplasm of all living cells. The protein produced by this gene has various functions in the cell, including the metabolism of nucleotides, such as hypoxanthine and guanine, which are essential for DNA replication, transcription, and translation.

HPRT1 is a key enzyme in the DNA replication process, as it is responsible for the transfer of the guanine nucleotide to the daughter DNA strand during the synthesis of DNA from the template strand. In addition, HPRT1 is also involved in the metabolism of hypoxanthine, which is a nucleotide that plays a critical role in the regulation of cell growth and differentiation.

The research on HPRT1 has led to the discovery of new potential drug targets and biomarkers. One of the main focuses of research is the development of drugs that can inhibit the activity of HPRT1, with the goal of treating various diseases, such as cancer, neurodegenerative diseases, and genetic disorders.

One of the most promising compounds that have been identified as potential HPRT1 inhibitors is called S63845, which is a drug that is currently being investigated for its potential utility as a treatment for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. S63845 works by inhibiting the activity of HPRT1, which results in the accumulation of hypoxanthine nucleotides in the brain and the progressive neurodegeneration that is associated with these diseases.

Another potential HPRT1 inhibitor is called Fasorubin, which is also being studied for its potential use in treating neurodegenerative diseases. Fasorubin works by inhibiting the activity of HPRT1 and hprt1, a gene that encodes the protein responsible for the metabolism of hypoxanthine nucleotides.

In addition to these drugs, researchers are also exploring the use of small molecules, such as drugs that modulate the activity of HPRT1, as potential biomarkers for the diagnosis and prognosis of neurodegenerative diseases. These small molecules can be used to label HPRT1 and hprt1 and then track their levels in the brain to monitor the progression of the disease.

Overall, HPRT1 is a gene that has significant implications for the study of DNA replication, neurodegenerative diseases, and drug development. The continued research on HPRT1 and its associated proteins is likely to lead to the discovery of new treatments and therapies for a variety of diseases.

Protein Name: Hypoxanthine Phosphoribosyltransferase 1

Functions: Converts guanine to guanosine monophosphate, and hypoxanthine to inosine monophosphate. Transfers the 5-phosphoribosyl group from 5-phosphoribosylpyrophosphate onto the purine. Plays a central role in the generation of purine nucleotides through the purine salvage pathway

The "HPRT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HPRT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets